Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-01

Clinical Trial Update: GTx-024 as a Treatment for Stress Urinary Incontinence in Women [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GTx-024 in stress urinary incontinence shows completed status with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GTx-024

Snippet

Sponsor: GTx | Conditions: Stress Urinary Incontinence | Phase 2 | Status: COMPLETED | Results posted: 2021-02-01